GB1444575A - Cephalosporin c isolation process and intermediate compounds therefor - Google Patents

Cephalosporin c isolation process and intermediate compounds therefor

Info

Publication number
GB1444575A
GB1444575A GB5050873A GB5050873A GB1444575A GB 1444575 A GB1444575 A GB 1444575A GB 5050873 A GB5050873 A GB 5050873A GB 5050873 A GB5050873 A GB 5050873A GB 1444575 A GB1444575 A GB 1444575A
Authority
GB
United Kingdom
Prior art keywords
cephalosporin
hydrogen
formula
impurities
polysaccharide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5050873A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00306130A external-priority patent/US3843642A/en
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1444575A publication Critical patent/GB1444575A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/12—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB5050873A 1972-11-13 1973-10-30 Cephalosporin c isolation process and intermediate compounds therefor Expired GB1444575A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00306130A US3843642A (en) 1972-11-13 1972-11-13 Cephalosporin c derivatives
US00398725A US3853863A (en) 1972-11-13 1973-09-19 Cephalosporin c isolation process

Publications (1)

Publication Number Publication Date
GB1444575A true GB1444575A (en) 1976-08-04

Family

ID=26974991

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5050873A Expired GB1444575A (en) 1972-11-13 1973-10-30 Cephalosporin c isolation process and intermediate compounds therefor

Country Status (24)

Country Link
US (1) US3853863A (enExample)
JP (1) JPS5721318B2 (enExample)
KR (1) KR780000012B1 (enExample)
AR (1) AR202466A1 (enExample)
AT (1) AT327386B (enExample)
AU (1) AU471843B2 (enExample)
CA (1) CA1016163A (enExample)
CH (1) CH599224A5 (enExample)
CS (1) CS192506B2 (enExample)
DD (1) DD112653A5 (enExample)
DE (1) DE2356122C2 (enExample)
ES (1) ES420336A1 (enExample)
FR (1) FR2207140B1 (enExample)
GB (1) GB1444575A (enExample)
HU (1) HU167596B (enExample)
IE (1) IE38382B1 (enExample)
IL (1) IL43560A (enExample)
NL (1) NL180106C (enExample)
PH (1) PH9509A (enExample)
PL (1) PL91577B1 (enExample)
RO (1) RO63260A (enExample)
SE (1) SE409713B (enExample)
SU (1) SU603343A3 (enExample)
YU (1) YU283173A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2458554A1 (de) * 1974-01-03 1975-07-10 Lepetit Spa Neues verfahren fuer die gewinnung von cephalosporin c aus einer fermentationsbruehe
GB1489231A (en) * 1974-02-20 1977-10-19 Alfa Farmaceutici Spa Process for the recovery of cephalosporin c and derivatives thereof
JPS557438B2 (enExample) * 1974-02-22 1980-02-25
US4168268A (en) * 1977-03-01 1979-09-18 Merck & Co., Inc. Process for isolating thienamycin
US4137405A (en) * 1977-07-28 1979-01-30 Merck & Co., Inc. Isolation of antibiotic Cephamycin C
FR2404642A1 (fr) * 1977-09-29 1979-04-27 Roussel Uclaf Nouveau derive de la cephalosporine c, procede de preparation et application du nouveau produit a la preparation de l'acide 7-amino cephalosporanique
AT367060B (de) * 1979-01-25 1982-05-25 Biochemie Gmbh Verfahren zur herstellung neuer cephalosporinderivate
JPS58143751A (ja) * 1982-02-19 1983-08-26 日本電熱株式会社 排便装置付ベツト
US5512454A (en) * 1994-02-03 1996-04-30 Bristol-Myers Squibb Company Enzymatic acylation of 3-hydroxymethyl cephalosporins

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3227709A (en) * 1961-11-28 1966-01-04 Merck & Co Inc Derivatives of cephalosporin c and process
US3234222A (en) * 1962-02-16 1966-02-08 Ciba Geigy Corp Preparation of 7-acylaminocephalosporanic acids
CH481142A (de) * 1966-12-05 1969-11-15 Ciba Geigy Verfahren zur Isolierung von Cephalosporin C
GB1311268A (en) * 1971-01-26 1973-03-28 Pfizer Process for the isolation of n-benzoyl cephalosporin c

Also Published As

Publication number Publication date
JPS49133595A (enExample) 1974-12-21
PL91577B1 (enExample) 1977-03-31
FR2207140B1 (enExample) 1977-06-03
DE2356122C2 (de) 1983-12-22
RO63260A (fr) 1978-06-15
AU6155573A (en) 1975-04-24
SE409713B (sv) 1979-09-03
AR202466A1 (es) 1975-06-13
CS192506B2 (en) 1979-08-31
ATA954273A (de) 1975-04-15
AT327386B (de) 1976-01-26
HU167596B (enExample) 1975-11-28
IE38382B1 (en) 1978-03-01
FR2207140A1 (enExample) 1974-06-14
SU603343A3 (ru) 1978-04-15
IE38382L (en) 1974-05-13
ES420336A1 (es) 1976-06-16
NL180106C (nl) 1987-01-02
IL43560A0 (en) 1974-03-14
CA1016163A (en) 1977-08-23
DD112653A5 (enExample) 1975-04-20
NL180106B (nl) 1986-08-01
NL7315480A (enExample) 1974-05-15
PH9509A (en) 1976-01-09
US3853863A (en) 1974-12-10
KR780000012B1 (en) 1978-03-04
DE2356122A1 (de) 1974-05-22
AU471843B2 (en) 1976-05-06
JPS5721318B2 (enExample) 1982-05-06
CH599224A5 (enExample) 1978-05-12
IL43560A (en) 1976-09-30
YU283173A (en) 1982-02-28

Similar Documents

Publication Publication Date Title
US3282926A (en) alpha-carboxy-3-thienylmethylpenicillin
KR850001220A (ko) 나트륨 세퓨록심의 개선된 제조방법
KR870001291B1 (ko) 세팔로 스포린의 제조방법
US3252973A (en) Acylation via carbodimides for penicillin and cephalosporin preparation
GB1413068A (en) Bromoergolines
JP3751880B2 (ja) 高純度セフポドキシムプロキセチルの製造方法
US3338897A (en) 7-(alpha-substituted acyl amino) cephalosporanic acid and derivatives thereof
IL43560A (en) Isolation process of cephalosporin C and intermediate compounds for it
US3775408A (en) Process for producing cephalosporin derivatives
NO140269B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefalosporinderivater
US3580908A (en) Process for the conversion of alpha-carboaryloxybenzylpenicillins to alpha-carboxybenzylpenicillins
US4327211A (en) Method for preparation of cephalosporin compounds
GB1436977A (en) 7-alkylthioacetamido cephaosporins
US3922268A (en) 3-Halomethyl-{66 {hu 3-Cephalosporin esters
EP0042220B1 (en) Process for the preparation of beta-lactam antibiotics
US4168375A (en) Process for the recovery of cephalosporin C and derivatives thereof
GB1324419A (en) Method of converting cephalosporin c to a derivative thereof
GB1439898A (en) Method of preparing substituted cephalosporins and penicillins
CA1157850A (en) PROCESS FOR THE PREPARATION OF .beta.-LACTAM ANTIBIOTICS
JPH06104670B2 (ja) 化学化合物の新規製法
GB1331718A (en) Process for the preparation of 4- pyridylthio acetic acid
GB1439093A (en) Process for the preparation of 5-nitronaphthoquinone-1,4
DE2841363C2 (enExample)
US4132849A (en) Process for the preparation of 3-hydroxymethyl cephalosporins
AT397086B (de) Verfahren zur herstellung von neuen 2-(2-aminothiazol-4-4yl)-2-(syn)-alkoxyimino- acetamiden

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee